Current Report Filing (8-k)
November 25 2019 - 4:11PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported)
November 21, 2019
INNERSCOPE HEARING TECHNOLOGIES, INC.
(Exact Name of Registrant as Specified in Charter)
Nevada
|
(State or Other Jurisdiction of Incorporation)
|
000-55754
|
|
46-3096516
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
2151 Professional Drive, 2nd Floor
Roseville, CA
|
|
95661
|
(Address of principal executive offices)
|
|
(Zip code)
|
(916) 218-4100
|
(Registrant’s telephone number, including area code)
|
Not applicable
|
(Former name or former address, if changed since last report)
|
Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
N/A
|
|
N/A
|
|
N/A
|
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☑
If an emerging growth company, indicate by
check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐
|
Item 3.02
|
Unregistered Sales of Equity Securities.
|
On November 21, 2019, the Board of Directors
authorized the issuance of 900,000 shares of InnerScope Hearing Technologies, Inc.’s (the “Company”) Series B
Preferred Stock. The shares will be issued as follows; 300,000 shares to the Company’s CEO and director, Matthew Moore (“Matthew’),
300,000 shares to the Company’s CFO and director, Kimberly Moore (“Kimberly”) and 300,000 shares to the Company’s
Chairman, Mark Moore (“Mark”). The Series B Preferred Stock authorized to be issued in consideration of the Company’s
failure to timely pay current and past salaries to Matthew and Kimberly, and their willingness to accrue unpaid payroll and the
non-reimbursement of business expenses without penalty or action for all amounts owed to Matthew and Kimberly and for compensation
to Mark. The issuances of the shares were made in reliance on the exemption from registration provided by Section 4(a)(2) of the
Securities Act as there was no general solicitation, and the transaction did not involve a public offering. There are now 1,800,000
shares of Series B Preferred Stock outstanding and Matthew, Kimberly and March each own 600,000 shares of Series B Preferred Stock
|
Item 5.03
|
Amendments to Articles of Incorporation
or Bylaws; Change in Fiscal Year.
|
On November 22, 2019, the Board of Directors
(the “Board”) of the Company approved the following corporate action (the “Corporate Action”):
The increase in the number of authorized shares
of stock from one billion (1,000,000,000) shares to fifteen billion (15,000,000,000) shares of stock (the "Authorized Stock
Share Increase"), whereby the authorized shares of common stock par value $0.0001, will increase from 975,000,000 shares to
14,975,000,000 shares and authorized shares of preferred stock will remain 25,000,000 shares, par value $0.0001. The Corporate
Action was approved by stockholders holding 89.96% of the outstanding shares of the Company in accordance with Section 78.320 of
the Nevada Revised Statutes.
In accordance with Regulation 14C promulgated
under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Company will file a definitive Information
Statement on Schedule 14C (the “Information Statement”) and will deliver a copy of the Information Statement to our
stockholders as of November 26, 2019, the Record Date. The Authorized Common Stock Share Increase will not become effective until
at least 20 calendar days after the first date of the delivery of the Information Statement.
After filing of the Information Statement,
we intend to file a Certificate of Amendment with the Secretary of State of the State of Nevada with Amended Articles of Incorporation
reflecting the Authorized Common Stock Share Increase to be effective at the expiration of the 20-calendar day period referenced
above.
On November 25, 2019, the Company filed in
the State of Nevada an Amended and Restated Certificate of Designation of the Series B Preferred Stock to increase the authorized
shares of Series B Preferred Stock from 900,000 shares to 1,800,000 shares designated as Series B Preferred Stock. The Series B
Preferred Stock is not convertible into common stock, nor does the Series B Preferred Stock have any right to dividends and any
liquidation preference. The Series B Preferred Stock entitles its holder to a number of votes per share equal to 1,000 votes.
The foregoing description of the rights and
preferences of the Amended and Restated Series B Preferred Stock are qualified in its entirety by the full text of the Amended
and Restated Certificate of Designation, which is filed as Exhibit 3.1, to, and incorporated by reference in, this report.
|
Item 5.07
|
Submission of Matters to a Vote of Security Holders
|
Reference is made to the disclosure set forth under Item 5.03 above,
which disclosure is incorporated herein by reference.
The Amendment is attached hereto as Exhibit
3.1 and is incorporated herein by reference.
|
Item 9.01
|
Financial Statements and Exhibits.
|
Exhibit No.
|
|
Description
|
|
|
|
3.1*
|
|
Amended and Restated Certificate of Designation of Series B Preferred Stock.
|
|
|
|
*Filed herewith.
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Date: November 25, 2019
INNERSCOPE HEARING TECHNOLOGIES,
INC.
By: /s/ Matthew Moore
Matthew Moore
Chief Executive Officer
Innerscope Hearing Techn... (PK) (USOTC:INND)
Historical Stock Chart
From Aug 2024 to Sep 2024
Innerscope Hearing Techn... (PK) (USOTC:INND)
Historical Stock Chart
From Sep 2023 to Sep 2024